Invention Grant
- Patent Title: Aqueous solution of burlulipase comprising calciumions
-
Application No.: US16490550Application Date: 2018-03-05
-
Publication No.: US11439691B2Publication Date: 2022-09-13
- Inventor: Richard Fuhrherr , Annika Müller-Lucks , Katharina Rützel , Jan Lüdemann , Martin Werner
- Applicant: Nordmark Pharma GmbH
- Applicant Address: DE Uetersen
- Assignee: Nordmark Pharma GmbH
- Current Assignee: Nordmark Pharma GmbH
- Current Assignee Address: DE Uetersen
- Agency: Grogan, Tuccillo & Vanderleeden LLP
- Priority: DE102017104480.9 20170303
- International Application: PCT/EP2018/055380 WO 20180305
- International Announcement: WO2018/158467 WO 20180907
- Main IPC: A61K38/46
- IPC: A61K38/46 ; A61K9/08 ; A61K47/02 ; C12N9/18 ; C12N9/96

Abstract:
The present invention relates to an aqueous solution comprising burlulipase which is characterized in that it contains calcium ions. In particular, it also relates to corresponding pharmaceuticals. Such pharmaceuticals are suitable for the treatment of exocrine pancreatic insufficiency. These pharmaceuticals are particularly suitable for treating patients having cystic fibrosis and in pediatrics. Another aspect of the present invention relates to container-packaged solutions and pharmaceuticals as mentioned above, which are containers produced by the blow-fill-seal method, and to methods for producing such packaged solutions and pharmaceuticals.
Public/Granted literature
- US20200009233A1 AQUEOUS SOLUTION OF BURLULIPASE COMPRISING CALCIUMIONS Public/Granted day:2020-01-09
Information query
IPC分类: